Soft tissue infections - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Disease ReportsSoft tissue infections

MeSH D018461 - soft tissue infections

Favorite

Competitive Landscape

Events Timeline

Commercial

Clinical Trials

Competitive landscape

D007239:Infections

$

Success rate

Soft tissue infections

$

Success rate

Events Timeline

Commercial

Company Name	Drug Name	Trade Name	Patent Expires	Approval Date	Revenue	Period
Teva	Ceftriaxone	Ceftriaxone		2007-03-15
	Linezolid	Linezolid		2015-05-18
	Cephalexin	Cephalexin		1982-01-01
	Cefazolin	Cefazolin		1989-03-14
	Amoxicillin	Amoxicillin		1982-01-01
	Amoxicillin, Clavulanate	Amoxicillin Clavulanate Potassium		2004-05-25
Glenmark Pharmaceuticals	Linezolid	Linezolid		2015-12-21
Mylan	Linezolid	Linezolid		2017-12-06
Mylan	Amoxicillin	Amoxicillin		1982-01-01
GSK	Cefazolin	Ancef		1982-01-01
	Cefazolin	Cefazolin		1993-10-31
	Amoxicillin	Amoxil		1982-01-01
	Amoxicillin	Larotid		1982-01-01
	Clavulanate, Ticarcillin	Timentin		1985-04-01
Roche	Ceftriaxone, Lidocaine	Rocephin		1985-03-12	$261.442 M	Y2021
Lupin Research	Ceftriaxone	Ceftriaxone		2003-09-30
Lupin Research	Cephalexin	Cephalexin		2005-11-25
Sandoz	Ceftriaxone	Ceftriaxone		2005-05-17
	Linezolid	Linezolid		2015-07-16
	Cefazolin	Cefazolin		1988-12-09
	Amoxicillin	Amoxicillin		1994-09-30
	Amoxicillin, Clavulanate	Amoxicillin Clavulanate Potassium		2002-03-14
	Amoxicillin, Lansoprazole, Clarithromycin	Lansoprazole, Amoxicillin Clarithromycin		2014-03-04

1

2

3

4

5

6

...

14

>

Clinical Trials

Historical Success Rate

Phase 1

0%

0/0

Phase 2

40%

2/5

Phase 3

87%

47/54

Approved: 44Overall Success rate: 0%

All Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Company name

Phase 1

Phase 2

Phase 3

Phase 4

Drug Name

Johnson & Johnson

Cefuroxime axetil,

Sodium chloride,

Clavulanic acid

1

2

3

4

5

6

...

9

>

© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use